![Timothy Pigot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Pigot
Corporate Officer/Principal bei
INHIBIKASE THERAPEUTICS, INC.
Profil
Timothy J Pigot is Chief Commercial & Strategy Officer at Inhibikase Therapeutics, Inc. since 2025.
Formerly, Mr. Pigot was Chief Commercial Officer at Jade Biosciences, Inc. from 2021 to 2024.
Education includes undergraduate studies at State University of New York at Binghamton.
Aktive Positionen von Timothy Pigot
| Unternehmen | Position | Beginn |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 19.08.2025 |
Ehemalige bekannte Positionen von Timothy Pigot
| Unternehmen | Position | Ende |
|---|---|---|
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | 01.08.2024 |
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Timothy Pigot
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
